BioSpace News Archive

Interscope, Inc. announced today the receipt of FDA de novo clearance to market its EndoRotor® System in the United States for direct endoscopic necrosectomy (DEN), a minimally invasive treatment

Proceeds will add resources for the Company’s Acclaim-1 and Acclaim-2 clinical trials in lung cancer, as well as its pre-clinical programs in cancer and diabetes

Core One Labs Inc. (CSE:COOL), (OTC:CLABF), (Frankfurt:LD62), (WKN:A14XHT) is pleased to announce that, further to its press release of October 7, 2020, it has entered into a definitive share purchase agreement dated December 23, 2020, for the acquisition of all of the outstanding share capital of Vocan Biotechnologies Inc.

The Government of Canada is aware that the United Kingdom is investigating a new SARS-CoV-2 variant, which has been identified in cases in areas where there is also a high incidence of COVID-19.

Audentes Therapeutics , an Astellas genetic medicines company, today announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold for the ASPIRO clinical trial evaluating AT132 in patients with X-linked myotubular myopathy (XLMTM). XLMTM is a serious, life-threatening neuromuscular disease characterized by extreme muscle weakness, respiratory failure, and early death. “We are grateful for t